Early erythropoietin for preventing red blood cell transfusion in preterm and/or low birth weight infants: Commentary

Neonatology

Volumn 102, Issue 2, 2012, Pages 127-129

  Soll, Roger F ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

DEXAMETHASONE; ERYTHROPOIETIN; INDOMETACIN; PLACEBO;

ANEMIA; DRUG EFFICACY; DRUG SAFETY; ERYTHROCYTE TRANSFUSION; HUMAN; HYPOXIC ISCHEMIC ENCEPHALOPATHY; LOW BIRTH WEIGHT; NEUROPROTECTION; NOTE; PREMATURE LABOR; PRIORITY JOURNAL; RETROLENTAL FIBROPLASIA; RISK FACTOR;

ANEMIA; DRUG ADMINISTRATION SCHEDULE; ERYTHROCYTE TRANSFUSION; ERYTHROPOIETIN; EVIDENCE-BASED MEDICINE; HEMATINICS; HUMANS; INFANT MORTALITY; INFANT, LOW BIRTH WEIGHT; INFANT, NEWBORN; INFANT, PREMATURE; INFANT, PREMATURE, DISEASES; RISK ASSESSMENT; RISK FACTORS; TIME FACTORS; TREATMENT OUTCOME;

EID: 84861993900     PISSN: 16617800     EISSN: 16617819     Source Type: Journal    
DOI: 10.1159/000338550     Document Type: Note

References (6)

1. Romagnoli C, Tesfagabir MG, Giannantonio C, Papacci P: Erythropoietin and retinopathy of prematurity. Early Hum Dev 2011; 87(suppl 1):S39-S42.
2. Suk KK, Dunbar JA, Liu A, Daher NS, Leng CK, Leng JK, Lim P, Weller S, Fayard E: Human recombinant erythropoietin and the incidence of retinopathy of prematurity: A multiple regression model. J AAPOS 2008; 12: 233-238.
3. McPherson RJ, Juul SE: Erythropoietin for infants with hypoxic-ischemic encephalopathy. Curr Opin Pediatr 2010; 22: 139-145.
4. Bishara N, Ohls RK: Current controversies in the management of the anemia of prematurity. Semin Perinatol 2009; 33: 29-34.
5. Clark RH, Bloom BT, Spitzer AR, Gerstmann DR: Reported medication use in the neonatal intensive care unit: data from a large national data set. Pediatrics 2006; 117: 1979-1987.
6. Von Kohorn I, Ehrenkranz RA: Anemia in the preterm infant: erythropoietin versus erythrocyte transfusion - it's not that simple. Clin Perinatol 2009; 36: 111-123.